Annual Working Capital
$7.42 M
-$4.20 M-36.14%
31 December 2023
Summary:
GT Biopharma annual working capital is currently $7.42 million, with the most recent change of -$4.20 million (-36.14%) on 31 December 2023. During the last 3 years, it has risen by +$36.86 million (+125.22%). GTBP annual working capital is now -66.12% below its all-time high of $21.91 million, reached on 31 December 2021.GTBP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$2.10 M
-$3.41 M-61.93%
30 September 2024
Summary:
GT Biopharma quarterly working capital is currently $2.10 million, with the most recent change of -$3.41 million (-61.93%) on 30 September 2024. Over the past year, it has dropped by -$8.87 million (-80.87%). GTBP quarterly working capital is now -94.22% below its all-time high of $36.29 million, reached on 30 June 2021.GTBP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.1% | -80.9% |
| 3 y3 years | +125.2% | -93.4% |
| 5 y5 years | +153.3% | +111.4% |
GTBP Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -66.1% | +125.2% | -93.4% | at low |
| 5 y | 5 years | -66.1% | +125.2% | -94.2% | +107.0% |
| alltime | all time | -66.1% | +114.9% | -94.2% | +104.2% |
GT Biopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.10 M(-61.9%) |
| June 2024 | - | $5.51 M(+4.2%) |
| Mar 2024 | - | $5.29 M(-28.8%) |
| Dec 2023 | $7.42 M(-36.1%) | $7.42 M(-32.3%) |
| Sept 2023 | - | $10.96 M(-16.8%) |
| June 2023 | - | $13.18 M(-16.9%) |
| Mar 2023 | - | $15.86 M(+36.5%) |
| Dec 2022 | $11.62 M(-46.9%) | $11.62 M(-26.6%) |
| Sept 2022 | - | $15.85 M(+3.3%) |
| June 2022 | - | $15.34 M(-13.3%) |
| Mar 2022 | - | $17.69 M(-19.3%) |
| Dec 2021 | $21.91 M(-174.4%) | $21.91 M(-31.3%) |
| Sept 2021 | - | $31.88 M(-12.2%) |
| June 2021 | - | $36.29 M(+51.1%) |
| Mar 2021 | - | $24.02 M(-181.6%) |
| Dec 2020 | -$29.43 M(+51.5%) | -$29.43 M(-1.4%) |
| Sept 2020 | - | -$29.86 M(+8.2%) |
| June 2020 | - | -$27.59 M(+31.6%) |
| Mar 2020 | - | -$20.96 M(+7.9%) |
| Dec 2019 | -$19.43 M(+39.4%) | -$19.43 M(+5.4%) |
| Sept 2019 | - | -$18.43 M(+12.1%) |
| June 2019 | - | -$16.45 M(+6.5%) |
| Mar 2019 | - | -$15.45 M(+10.8%) |
| Dec 2018 | -$13.94 M(+562.8%) | -$13.94 M(+16.4%) |
| Sept 2018 | - | -$11.98 M(+52.4%) |
| June 2018 | - | -$7.86 M(+256.1%) |
| Mar 2018 | - | -$2.21 M(+4.9%) |
| Dec 2017 | -$2.10 M(-88.9%) | -$2.10 M(+2904.3%) |
| Sept 2017 | - | -$70.00 K(-99.7%) |
| June 2017 | - | -$20.09 M(+10.9%) |
| Mar 2017 | - | -$18.11 M(-4.3%) |
| Dec 2016 | -$18.93 M(-62.0%) | -$18.93 M(+12.6%) |
| Sept 2016 | - | -$16.81 M(+9.8%) |
| June 2016 | - | -$15.31 M(-22.2%) |
| Mar 2016 | - | -$19.67 M(-60.5%) |
| Dec 2015 | -$49.86 M(+72.3%) | -$49.86 M(+123.9%) |
| Sept 2015 | - | -$22.26 M(+3.8%) |
| June 2015 | - | -$21.45 M(-56.3%) |
| Mar 2015 | - | -$49.09 M(+69.6%) |
| Dec 2014 | -$28.95 M(+362.5%) | -$28.95 M(+172.6%) |
| Sept 2014 | - | -$10.62 M(+55.5%) |
| June 2014 | - | -$6.83 M(+3.4%) |
| Mar 2014 | - | -$6.60 M(+5.5%) |
| Dec 2013 | -$6.26 M(-1.6%) | -$6.26 M(+4.5%) |
| Sept 2013 | - | -$5.99 M(+6.5%) |
| June 2013 | - | -$5.63 M(+5.9%) |
| Mar 2013 | - | -$5.31 M(-16.5%) |
| Dec 2012 | -$6.36 M(+24.1%) | -$6.36 M(+1.7%) |
| Sept 2012 | - | -$6.25 M(-3.1%) |
| June 2012 | - | -$6.45 M(+22.0%) |
| Mar 2012 | - | -$5.29 M(+3.1%) |
| Dec 2011 | -$5.13 M(-7.1%) | -$5.13 M(+3.9%) |
| Sept 2011 | - | -$4.93 M(-12.0%) |
| June 2011 | - | -$5.60 M(-20.7%) |
| Mar 2011 | - | -$7.07 M(+28.1%) |
| Dec 2010 | -$5.52 M(-0.9%) | -$5.52 M(+11.9%) |
| Sept 2010 | - | -$4.93 M(-4.6%) |
| June 2010 | - | -$5.17 M(-22.9%) |
| Mar 2010 | - | -$6.70 M(+20.4%) |
| Dec 2009 | -$5.57 M(+39.3%) | -$5.57 M(+14.5%) |
| Sept 2009 | - | -$4.86 M(+5.5%) |
| June 2009 | - | -$4.61 M(+8.0%) |
| Mar 2009 | - | -$4.27 M(+6.8%) |
| Dec 2008 | -$4.00 M(+593.6%) | -$4.00 M(-1.8%) |
| Sept 2008 | - | -$4.07 M(+22.1%) |
| June 2008 | - | -$3.33 M(+125.3%) |
| Mar 2008 | - | -$1.48 M(+156.9%) |
| Dec 2007 | -$576.00 K(-70.5%) | -$576.00 K(+93.9%) |
| Sept 2007 | - | -$297.00 K(-64.7%) |
| June 2007 | - | -$842.00 K(-61.9%) |
| Mar 2007 | - | -$2.21 M(+13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | -$1.95 M(-260.8%) | -$1.95 M(>+9900.0%) |
| Sept 2006 | - | -$9000.00(-103.4%) |
| June 2006 | - | $266.00 K(-62.5%) |
| Mar 2006 | - | $709.00 K(-41.6%) |
| Dec 2005 | $1.21 M(-75.0%) | $1.21 M(-69.7%) |
| Sept 2005 | - | $4.01 M(-9.9%) |
| June 2005 | - | $4.45 M(-6.8%) |
| Mar 2005 | - | $4.78 M(-1.7%) |
| Dec 2004 | $4.86 M(<-9900.0%) | $4.86 M(-470.1%) |
| Sept 2004 | - | -$1.31 M(+7.3%) |
| June 2004 | - | -$1.22 M(+2348.0%) |
| Mar 2004 | - | -$50.00 K(+38.9%) |
| Dec 2003 | -$36.00 K(-112.7%) | -$36.00 K(+227.3%) |
| Sept 2003 | - | -$11.00 K(-92.1%) |
| June 2003 | - | -$140.00 K(-169.0%) |
| Mar 2003 | - | $203.00 K(-28.5%) |
| Dec 2002 | $284.00 K(-159.2%) | $284.00 K(-37.4%) |
| Sept 2002 | - | $454.00 K(-33.7%) |
| June 2002 | - | $685.00 K(-20.4%) |
| Mar 2002 | - | $861.00 K(-279.4%) |
| Dec 2001 | -$480.00 K(-119.1%) | -$480.00 K(+146.2%) |
| Sept 2001 | - | -$195.00 K(-230.9%) |
| June 2001 | - | $149.00 K(-89.8%) |
| Mar 2001 | - | $1.46 M(-41.9%) |
| Dec 2000 | $2.51 M(+171.8%) | $2.51 M(-36.3%) |
| Sept 2000 | - | $3.94 M(-22.0%) |
| June 2000 | - | $5.05 M(+7.8%) |
| Mar 2000 | - | $4.69 M(+407.1%) |
| Dec 1999 | $924.00 K(-69.2%) | $924.00 K(-23.0%) |
| Sept 1999 | - | $1.20 M(-45.5%) |
| June 1999 | - | $2.20 M(-18.5%) |
| Mar 1999 | - | $2.70 M(-10.0%) |
| Dec 1998 | $3.00 M(+233.3%) | $3.00 M(-31.8%) |
| Sept 1998 | - | $4.40 M(+18.9%) |
| June 1998 | - | $3.70 M(-840.0%) |
| Mar 1998 | - | -$500.00 K(-155.6%) |
| Dec 1997 | $900.00 K(-164.3%) | $900.00 K(-40.0%) |
| Sept 1997 | - | $1.50 M(-42.3%) |
| June 1997 | - | $2.60 M(-204.0%) |
| Mar 1997 | - | -$2.50 M(+78.6%) |
| Dec 1996 | -$1.40 M(0.0%) | -$1.40 M(+55.6%) |
| Sept 1996 | - | -$900.00 K(-400.0%) |
| June 1996 | - | $300.00 K(-115.0%) |
| Mar 1996 | - | -$2.00 M(+42.9%) |
| Dec 1995 | -$1.40 M(+40.0%) | -$1.40 M(+100.0%) |
| Sept 1995 | - | -$700.00 K(-12.5%) |
| June 1995 | - | -$800.00 K(-46.7%) |
| Mar 1995 | - | -$1.50 M(+50.0%) |
| Dec 1994 | -$1.00 M(-138.5%) | -$1.00 M(+66.7%) |
| Sept 1994 | - | -$600.00 K(-140.0%) |
| June 1994 | - | $1.50 M(-37.5%) |
| Mar 1994 | - | $2.40 M(-7.7%) |
| Dec 1993 | $2.60 M(-36.6%) | $2.60 M(0.0%) |
| Sept 1993 | - | $2.60 M(-16.1%) |
| June 1993 | - | $3.10 M(-24.4%) |
| Mar 1993 | - | $4.10 M(0.0%) |
| Dec 1992 | $4.10 M(-6.8%) | $4.10 M(-2.4%) |
| Sept 1992 | - | $4.20 M(-4.5%) |
| June 1992 | - | $4.40 M(+4.8%) |
| Mar 1992 | - | $4.20 M(-4.5%) |
| Dec 1991 | $4.40 M(-6.4%) | $4.40 M(-4.3%) |
| Sept 1991 | - | $4.60 M(-2.1%) |
| Dec 1990 | $4.70 M(+23.7%) | $4.70 M(+23.7%) |
| Dec 1989 | $3.80 M(+31.0%) | $3.80 M(+31.0%) |
| Dec 1988 | $2.90 M(+11.5%) | $2.90 M(+11.5%) |
| Dec 1987 | $2.60 M(+13.0%) | $2.60 M(+13.0%) |
| Dec 1986 | $2.30 M(-14.8%) | $2.30 M(-14.8%) |
| Dec 1985 | $2.70 M(-12.9%) | $2.70 M(-12.9%) |
| Dec 1984 | $3.10 M(+3.3%) | - |
| Dec 1984 | - | $3.10 M |
| Feb 1984 | $3.00 M | - |
FAQ
- What is GT Biopharma annual working capital?
- What is the all time high annual working capital for GT Biopharma?
- What is GT Biopharma annual working capital year-on-year change?
- What is GT Biopharma quarterly working capital?
- What is the all time high quarterly working capital for GT Biopharma?
- What is GT Biopharma quarterly working capital year-on-year change?
What is GT Biopharma annual working capital?
The current annual working capital of GTBP is $7.42 M
What is the all time high annual working capital for GT Biopharma?
GT Biopharma all-time high annual working capital is $21.91 M
What is GT Biopharma annual working capital year-on-year change?
Over the past year, GTBP annual working capital has changed by -$4.20 M (-36.14%)
What is GT Biopharma quarterly working capital?
The current quarterly working capital of GTBP is $2.10 M
What is the all time high quarterly working capital for GT Biopharma?
GT Biopharma all-time high quarterly working capital is $36.29 M
What is GT Biopharma quarterly working capital year-on-year change?
Over the past year, GTBP quarterly working capital has changed by -$8.87 M (-80.87%)